HC Wainwright & Co. Maintains Buy on Syndax Pharmaceuticals, Raises Price Target to $51
HC Wainwright & Co. Maintains Buy on Syndax Pharmaceuticals, Raises Price Target to $51
HC Wainwright公司维持对syndax pharmaceuticals的买入评级，将目标股价上调至51美元
HC Wainwright & Co. analyst Edward White maintains Syndax Pharmaceuticals (NASDAQ:SNDX) with a Buy and raises the price target from $49 to $51.
HC Wainwright分析师Edward White维持对syndax pharmaceuticals（纳斯达克：SNDX）的买入评级，并将目标股价从49美元上调至51美元。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
资讯热榜
更新时间